MiR-93 enhances angiogenesis and metastasis by targeting LATS2

References

• Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003; 425:415 - 9; http://dx.doi.org/10.1038/nature01957; PMID: 14508493
   PubMed Web of Science ®Google Scholar
• Lai EC. Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 2002; 30:363 - 4; http://dx.doi.org/10.1038/ng865; PMID: 11896390
   PubMed Web of Science ®Google Scholar
• Lee DY, Shatseva T, Jeyapalan Z, Du WW, Deng Z, Yang BB. A 3′-untranslated region (3’UTR) induces organ adhesion by regulating miR-199a* functions. PLoS One 2009; 4:e4527; http://dx.doi.org/10.1371/journal.pone.0004527; PMID: 19223980
   PubMedGoogle Scholar
• Jeyapalan Z, Deng Z, Shatseva T, Fang L, He C, Yang BB. Expression of CD44 3′-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis. Nucleic Acids Res 2011; 39:3026 - 41; http://dx.doi.org/10.1093/nar/gkq1003; PMID: 21149267
   PubMed Web of Science ®Google Scholar
• Lee SC, Fang L, Wang CH, Kahai S, Deng Z, Yang BB. A non-coding transcript of nephronectin promotes osteoblast differentiation by modulating microRNA functions. FEBS Lett 2011; 585:2610 - 6; http://dx.doi.org/10.1016/j.febslet.2011.07.016; PMID: 21784074
   PubMed Web of Science ®Google Scholar
• Viticchiè G, Lena AM, Latina A, Formosa A, Gregersen LH, Lund AH, et al. MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines. Cell Cycle 2011; 10:1121 - 31; http://dx.doi.org/10.4161/cc.10.7.15180; PMID: 21368580
   PubMed Web of Science ®Google Scholar
• Shatseva T, Lee DY, Deng Z, Yang BB. MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2. J Cell Sci 2011; 124:2826 - 36; http://dx.doi.org/10.1242/jcs.077529; PMID: 21807947
   PubMed Web of Science ®Google Scholar
• Hidaka H, Seki N, Yoshino H, Yamasaki T, Yamada Y, Nohata N, et al. Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma. Oncotarget 2012; 3:44 - 57; PMID: 22294552
   PubMed Web of Science ®Google Scholar
• Kahai S, Lee SC, Lee DY, Yang J, Li M, Wang CH, et al. MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7. PLoS One 2009; 4:e7535; http://dx.doi.org/10.1371/journal.pone.0007535; PMID: 19844573
   PubMed Web of Science ®Google Scholar
• Luo L, Ye G, Nadeem L, Fu G, Yang BB, Honarparvar E, et al. MicroRNA-378a-5p promotes trophoblast cell survival, migration and invasion by targeting Nodal. J Cell Sci 2012; 125:3124 - 32; http://dx.doi.org/10.1242/jcs.096412; PMID: 22454525
   PubMed Web of Science ®Google Scholar
• Wang CH, Lee DY, Deng Z, Jeyapalan Z, Lee SC, Kahai S, et al. MicroRNA miR-328 regulates zonation morphogenesis by targeting CD44 expression. PLoS One 2008; 3:e2420; http://dx.doi.org/10.1371/journal.pone.0002420; PMID: 18560585
   PubMedGoogle Scholar
• Shan SW, Lee DY, Deng Z, Shatseva T, Jeyapalan Z, Du WW, et al. MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Nat Cell Biol 2009; 11:1031 - 8; http://dx.doi.org/10.1038/ncb1917; PMID: 19633662
   PubMed Web of Science ®Google Scholar
• Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006; 103:2257 - 61; http://dx.doi.org/10.1073/pnas.0510565103; PMID: 16461460
   PubMed Web of Science ®Google Scholar
• Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T, Hammond SM. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev 2006; 20:2202 - 7; http://dx.doi.org/10.1101/gad.1444406; PMID: 16882971
   PubMed Web of Science ®Google Scholar
• Nohata N, Hanazawa T, Enokida H, Seki N. microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers. Oncotarget 2012; 3:9 - 21; PMID: 22308266
   PubMed Web of Science ®Google Scholar
• Fang L, Deng Z, Shatseva T, Yang J, Peng C, Du WW, et al. MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8. Oncogene 2011; 30:806 - 21; http://dx.doi.org/10.1038/onc.2010.465; PMID: 20956944
   PubMed Web of Science ®Google Scholar
• Zou C, Xu Q, Mao F, Li D, Bian C, Liu LZ, et al. MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF. Cell Cycle 2012; 11:2137 - 45; http://dx.doi.org/10.4161/cc.20598; PMID: 22592534
   PubMed Web of Science ®Google Scholar
• Lee DY, Deng Z, Wang CH, Yang BB. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci U S A 2007; 104:20350 - 5; http://dx.doi.org/10.1073/pnas.0706901104; PMID: 18077375
   PubMed Web of Science ®Google Scholar
• Smits M, Nilsson J, Mir SE, van der Stoop PM, Hulleman E, Niers JM, et al. miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis. Oncotarget 2010; 1:710 - 20; PMID: 21321380
   PubMed Web of Science ®Google Scholar
• Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449:682 - 8; http://dx.doi.org/10.1038/nature06174; PMID: 17898713
   PubMed Web of Science ®Google Scholar
• Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S, et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 2008; 10:202 - 10; http://dx.doi.org/10.1038/ncb1681; PMID: 18193036
   PubMed Web of Science ®Google Scholar
• Rutnam ZJ, Yang BB. The involvement of microRNAs in malignant transformation. Histol Histopathol 2012; 27:1263 - 70; PMID: 22936445
   PubMed Web of Science ®Google Scholar
• Ory B, Ellisen LW. A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunity. Oncotarget 2011; 2:259 - 64; PMID: 21436470
   PubMed Web of Science ®Google Scholar
• Yang X, Rutnam ZJ, Jiao C, Wei D, Xie Y, Du J, et al. An anti-let-7 sponge decoys and decays endogenous let-7 functions. Cell Cycle 2012; 11:3097 - 108; http://dx.doi.org/10.4161/cc.21503; PMID: 22871741
   PubMed Web of Science ®Google Scholar
• Yang W, Lee DY, Ben-David Y. The roles of microRNAs in tumorigenesis and angiogenesis. Int J Physiol Pathophysiol Pharmacol 2011; 3:140 - 55; PMID: 21760972
   PubMedGoogle Scholar
• Altuvia Y, Landgraf P, Lithwick G, Elefant N, Pfeffer S, Aravin A, et al. Clustering and conservation patterns of human microRNAs. Nucleic Acids Res 2005; 33:2697 - 706; http://dx.doi.org/10.1093/nar/gki567; PMID: 15891114
   PubMed Web of Science ®Google Scholar
• Koralov SB, Muljo SA, Galler GR, Krek A, Chakraborty T, Kanellopoulou C, et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 2008; 132:860 - 74; http://dx.doi.org/10.1016/j.cell.2008.02.020; PMID: 18329371
   PubMed Web of Science ®Google Scholar
• Sylvestre Y, De Guire V, Querido E, Mukhopadhyay UK, Bourdeau V, Major F, et al. An E2F/miR-20a autoregulatory feedback loop. J Biol Chem 2007; 282:2135 - 43; http://dx.doi.org/10.1074/jbc.M608939200; PMID: 17135249
   PubMed Web of Science ®Google Scholar
• Mendell JT. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008; 133:217 - 22; http://dx.doi.org/10.1016/j.cell.2008.04.001; PMID: 18423194
   PubMed Web of Science ®Google Scholar
• Bonauer A, Dimmeler S. The microRNA-17-92 cluster: still a miRacle?. Cell Cycle 2009; 8:3866 - 73; http://dx.doi.org/10.4161/cc.8.23.9994; PMID: 19887902
   PubMed Web of Science ®Google Scholar
• Matsubara H, Takeuchi T, Nishikawa E, Yanagisawa K, Hayashita Y, Ebi H, et al. Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene 2007; 26:6099 - 105; http://dx.doi.org/10.1038/sj.onc.1210425; PMID: 17384677
   PubMed Web of Science ®Google Scholar
• Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005; 65:9628 - 32; http://dx.doi.org/10.1158/0008-5472.CAN-05-2352; PMID: 16266980
   PubMed Web of Science ®Google Scholar
• Mendell JT. MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle 2005; 4:1179 - 84; http://dx.doi.org/10.4161/cc.4.9.2032; PMID: 16096373
   PubMed Web of Science ®Google Scholar
• Landais S, Landry S, Legault P, Rassart E. Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res 2007; 67:5699 - 707; http://dx.doi.org/10.1158/0008-5472.CAN-06-4478; PMID: 17575136
   PubMed Web of Science ®Google Scholar
• Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008; 132:875 - 86; http://dx.doi.org/10.1016/j.cell.2008.02.019; PMID: 18329372
   PubMed Web of Science ®Google Scholar
• Dang CV. MYC, microRNAs and glutamine addiction in cancers. Cell Cycle 2009; 8:3243 - 5; http://dx.doi.org/10.4161/cc.8.20.9522; PMID: 19806017
   PubMed Web of Science ®Google Scholar
• Li Y, Tan W, Neo TW, Aung MO, Wasser S, Lim SG, et al. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci 2009; 100:1234 - 42; http://dx.doi.org/10.1111/j.1349-7006.2009.01164.x; PMID: 19486339
   PubMed Web of Science ®Google Scholar
• Yeung ML, Yasunaga J, Bennasser Y, Dusetti N, Harris D, Ahmad N, et al. Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. Cancer Res 2008; 68:8976 - 85; http://dx.doi.org/10.1158/0008-5472.CAN-08-0769; PMID: 18974142
   PubMed Web of Science ®Google Scholar
• Du L, Schageman JJ, Subauste MC, Saber B, Hammond SM, Prudkin L, et al. miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol Cancer Res 2009; 7:1234 - 43; http://dx.doi.org/10.1158/1541-7786.MCR-08-0507; PMID: 19671678
   PubMed Web of Science ®Google Scholar
• Mu P, Han YC, Betel D, Yao E, Squatrito M, Ogrodowski P, et al. Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev 2009; 23:2806 - 11; http://dx.doi.org/10.1101/gad.1872909; PMID: 20008931
   PubMed Web of Science ®Google Scholar
• Visser S, Yang X. LATS tumor suppressor: a new governor of cellular homeostasis. Cell Cycle 2010; 9:3892 - 903; http://dx.doi.org/10.4161/cc.9.19.13386; PMID: 20935475
   PubMed Web of Science ®Google Scholar
• Li Y, Pei J, Xia H, Ke H, Wang H, Tao W. Lats2, a putative tumor suppressor, inhibits G1/S transition. Oncogene 2003; 22:4398 - 405; http://dx.doi.org/10.1038/sj.onc.1206603; PMID: 12853976
   PubMed Web of Science ®Google Scholar
• Paramasivam M, Sarkeshik A, Yates JR 3rd, Fernandes MJ, McCollum D. Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor. Mol Biol Cell 2011; 22:3725 - 33; http://dx.doi.org/10.1091/mbc.E11-04-0300; PMID: 21832154
   PubMed Web of Science ®Google Scholar
• Cornils H, Kohler RS, Hergovich A, Hemmings BA. Downstream of human NDR kinases: impacting on c-myc and p21 protein stability to control cell cycle progression. Cell Cycle 2011; 10:1897 - 904; http://dx.doi.org/10.4161/cc.10.12.15826; PMID: 21593588
   PubMed Web of Science ®Google Scholar
• Aylon Y, Michael D, Shmueli A, Yabuta N, Nojima H, Oren M. A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev 2006; 20:2687 - 700; http://dx.doi.org/10.1101/gad.1447006; PMID: 17015431
   PubMed Web of Science ®Google Scholar
• Yabuta N, Mukai S, Okada N, Aylon Y, Nojima H. The tumor suppressor Lats2 is pivotal in Aurora A and Aurora B signaling during mitosis. Cell Cycle 2011; 10:2724 - 36; http://dx.doi.org/10.4161/cc.10.16.16873; PMID: 21822051
   PubMed Web of Science ®Google Scholar
• Tschöp K, Conery AR, Litovchick L, Decaprio JA, Settleman J, Harlow E, et al. A kinase shRNA screen links LATS2 and the pRB tumor suppressor. Genes Dev 2011; 25:814 - 30; http://dx.doi.org/10.1101/gad.2000211; PMID: 21498571
   PubMed Web of Science ®Google Scholar
• Rutnam ZJ, Yang BB. The non-coding 3′ UTR of CD44 induces metastasis by regulating extracellular matrix functions. J Cell Sci 2012; 125:2075 - 85; PMID: 22637644
   PubMed Web of Science ®Google Scholar
• Wu QP, Xie YZ, Deng Z, Li XM, Yang W, Jiao CW, et al. Ergosterol Peroxide Isolated from Ganoderma lucidum Abolishes MicroRNA miR-378-Mediated Tumor Cells on Chemoresistance. PLoS One 2012; 7:e44579; http://dx.doi.org/10.1371/journal.pone.0044579; PMID: 22952996
   PubMed Web of Science ®Google Scholar
• LaPierre DP, Lee DY, Li SZ, Xie YZ, Zhong L, Sheng W, et al. The ability of versican to simultaneously cause apoptotic resistance and sensitivity. Cancer Res 2007; 67:4742 - 50; http://dx.doi.org/10.1158/0008-5472.CAN-06-3610; PMID: 17510402
   PubMed Web of Science ®Google Scholar
• Yee AJ, Akens M, Yang BL, Finkelstein J, Zheng PS, Deng Z, et al. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis. Breast Cancer Res 2007; 9:R47; http://dx.doi.org/10.1186/bcr1751; PMID: 17662123
   PubMedGoogle Scholar